The FDA cleared Access MeMed BV, a host-response blood test that helps distinguish bacterial from viral infections in adults and children in as little as 15 minutes.
|Articles|April 19, 2021
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 19, 2021
Author(s)Sydney Jennings
Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.
Advertisement
How many people in the US have been vaccinated against COVID-19?
According to the US
• 39.9% of total US population have received at least 1 dose
• 25.7% of total US population are fully vaccinated
• 25.7% of total US population are fully vaccinated
The 5 states with the highest percentage of population fully vaccinated are:
1. Maine: 33.3%
2. New Mexico: 32.6%
3. Alaska: 32.2%
4. Connecticut: 32.2%
5. Rhode Island: 31.9%
2. New Mexico: 32.6%
3. Alaska: 32.2%
4. Connecticut: 32.2%
5. Rhode Island: 31.9%
How many cases of COVID-19 have been confirmed in the US?
According to the
• 31 670 846 confirmed cases
• 567 216 deaths
• 567 216 deaths
The 5 states with the highest total confirmed cases are:
1. California: 3 718 210
2. Texas: 2 850 668
3. Florida: 2 168 901
4. New York: 1 998 912
5. Illinois: 1 302 134
2. Texas: 2 850 668
3. Florida: 2 168 901
4. New York: 1 998 912
5. Illinois: 1 302 134
Deaths: California has the most deaths due to COVID-19 with 61 033 reported fatalities, followed by New York with 51 579, and Texas with 49 595.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 141 525 400 confirmed cases, 3 022 126 deaths, and 80 893 313 recoveries.
Advertisement
Related to this article
Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
Evolocumab was associated with a 20% lower risk of fatal or nonfatal myocardial infarction than ezetimibe among more than 544 000 adults with ASCVD.
Greater Mediterranean diet adherence was associated with lower odds of adult acne, particularly among women, in a UK Biobank study of dietary patterns.
Abbott's investigational device achieved 96.3% complete left atrial appendage closure by echocardiography, with a 1.8% ischemic stroke rate at 1 year.
October FDA news included updates on long-acting olanzapine, multi-cancer blood testing, stroke rehabilitation, and heart failure monitoring.
Christoph Correll, MD, discusses the new once-monthly olanzapine injection for schizophrenia, including clinical efficacy, metabolic risks, and patient selection.
Cheryl Cox Kinney, MD, explains when night sweats warrant further evaluation, including red flags, persistent symptoms, and potential nonmenopausal causes.
Advertisement
Advertisement